Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors

Author(s): A. Speck-Planche, F. Luan, M. N.D.S. Cordeiro

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 6 , 2012

Become EABM
Become Reviewer
Call for Editor


Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive dementia and loss of cognitive abilities. Until now, AD remains incurable. The principal biological target for AD therapy is acetylcholinesterase (AChE). Thus, the search for new drug candidates like AChE inhibitors constitutes an essential part for the discovery of more potent anti-AD agents. In general terms, rational drug design methodologies have played a decisive role. The present work is focused on the current state of the Ligand-Based Drug Design (LBDD) methods which have been applied to the elucidation of new molecular entities with high anti-AChE activity. Also, as a contribution to this field, we suggest a promising fragment-based approach for the search and prediction of new AChE inhibitors and for the fast and efficient extraction of substructural alerts which are responsible for the anti-AChE activity.

Keywords: AChE inhibitors, QSAR, 3D-QSAR, linear discriminant analysis, fragments, AChE, anti-AD agents, Ligand-Based Virtual Screening (LB-VS), parsimony, ArOCON, LBDD

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 01 May, 2012
Page: [583 - 591]
Pages: 9
DOI: 10.2174/138955712800493744
Price: $65

Article Metrics

PDF: 13